Chronic pain patients (CPPs) are at high risk for suicidality, which could be increased in the context of opioid tapering. This session presents recent research in this area along with monitoring techniques for suicidality development in CPPs undergoing opioid tapering. In addition, evaluation/treatment procedures for such CPPs will be discussed.
Suicidality and Chronic Pain: Research Status, Risk Factors, and Opioid Tapering Impact
David A. Fishbain, MD
Suicidality Monitoring/Evaluation/Treatment in the Chronic Pain Setting in the Context of Opioid Tapering
W. Michael Hooten, MD
- Recognize the high risk for suicidality of the CPP, which may be heightened in the context of opioid tapering.
- Examine monitoring /evaluation /treatment procedures for CPPs undergoing opioid tapering.
- Multidisciplinary Care Model and Contemporary Strategies for Intrathecal Drug Delivery (203)
- Ketamine for Pain, Depression, and Post-Traumatic Stress Disorder (PTSD): What Do We Know? (206)
- Neuropathic Pain: Beyond Adjuvants and Opioids: A Look at New and Reemerging Treatments (207)
- Collecting Patient-Reported Outcomes (PROs) to Enhance Your Practice and What the Collected Registry Data Tells Us So Far (210)
- A Pain in the Rear: Diagnosing and Treating Lumbar Spine and Sacroiliac Complex Pain (212)